Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Parmentier

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Journal of Hazardous Materials|October 11, 2016
Complete removal of arsenic and zinc from a heavily contaminated acid mine drainage via an indigenous SRB consortiumPierre Le Pape, Fabienne Battaglia-Brunet, Marc Parmentier, et al.
The Journal of Experimental Medicine|December 31, 2008
Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitmentCristina Albanesi, Claudia Scarponi, Sabatino Pallotta, et al.
Blood|October 29, 2010
Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3Sofie Struyf, Laura Salogni, Marie D Burdick, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2006
RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesiaFrédéric Simonin, Martine Schmitt, Jean-Paul Laulin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2009
Significance of N-terminal proteolysis of CCL14a to activity on the chemokine receptors CCR1 and CCR5 and the human cytomegalovirus-encoded chemokine receptor US28Rudolf Richter, Paola Casarosa, Ludger Ständker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 25, 2014
PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosisBenjamin Bondue, Félicie Sherer, Gaetan Van Simaeys, et al.
Journal of Neurochemistry|July 2, 2004
Substitution of conserved glycine residue by alanine in natural and synthetic neuropeptide ligands causes partial agonism at the stomoxytachykinin receptorJeroen Poels, Tom Van Loy, Vanessa Franssens, et al.
The Journal of Experimental Medicine|February 25, 2005
Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skinWilliam Vermi, Elena Riboldi, Valerie Wittamer, et al.
Peptides|November 15, 2002
Functional analysis of synthetic insectatachykinin analogs on recombinant neurokinin receptor expressing cell linesHerbert Torfs, Karl E Akerman, Ronald J Nachman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptorJi-Liang Gao, Aude Guillabert, Jinyue Hu, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Journal of Hazardous Materials|October 11, 2016
Complete removal of arsenic and zinc from a heavily contaminated acid mine drainage via an indigenous SRB consortiumPierre Le Pape, Fabienne Battaglia-Brunet, Marc Parmentier, et al.
The Journal of Experimental Medicine|December 31, 2008
Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitmentCristina Albanesi, Claudia Scarponi, Sabatino Pallotta, et al.
Blood|October 29, 2010
Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3Sofie Struyf, Laura Salogni, Marie D Burdick, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2006
RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesiaFrédéric Simonin, Martine Schmitt, Jean-Paul Laulin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2009
Significance of N-terminal proteolysis of CCL14a to activity on the chemokine receptors CCR1 and CCR5 and the human cytomegalovirus-encoded chemokine receptor US28Rudolf Richter, Paola Casarosa, Ludger Ständker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 25, 2014
PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosisBenjamin Bondue, Félicie Sherer, Gaetan Van Simaeys, et al.
Journal of Neurochemistry|July 2, 2004
Substitution of conserved glycine residue by alanine in natural and synthetic neuropeptide ligands causes partial agonism at the stomoxytachykinin receptorJeroen Poels, Tom Van Loy, Vanessa Franssens, et al.
The Journal of Experimental Medicine|February 25, 2005
Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skinWilliam Vermi, Elena Riboldi, Valerie Wittamer, et al.
Peptides|November 15, 2002
Functional analysis of synthetic insectatachykinin analogs on recombinant neurokinin receptor expressing cell linesHerbert Torfs, Karl E Akerman, Ronald J Nachman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptorJi-Liang Gao, Aude Guillabert, Jinyue Hu, et al.
Pageof 12